• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems.影响在开发注射型药物传递系统中动物模型的使用和解释的因素。
AAPS J. 2011 Dec;13(4):632-49. doi: 10.1208/s12248-011-9303-8. Epub 2011 Oct 5.
2
Parenteral drug delivery: a review.肠胃外给药:综述
Recent Pat Drug Deliv Formul. 2011 May;5(2):133-45. doi: 10.2174/187221111795471391.
3
Biodegradable microspheres for parenteral delivery.用于肠胃外给药的可生物降解微球。
Crit Rev Ther Drug Carrier Syst. 2005;22(6):535-602. doi: 10.1615/critrevtherdrugcarriersyst.v22.i6.20.
4
Recent advances in polymeric microspheres for parenteral drug delivery--part 1.聚合物微球在注射给药中的最新进展——第 1 部分。
Expert Opin Drug Deliv. 2012 Sep;9(9):1161-76. doi: 10.1517/17425247.2012.709844. Epub 2012 Jul 27.
5
Drug delivery to the lymphatic system.药物向淋巴系统的递送。
Crit Rev Ther Drug Carrier Syst. 1997;14(4):333-93.
6
Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products.AAPS/CRS 联合研讨会关于注射用缓控释产品在体内外性能的关键变量的突破性会议总结。
J Control Release. 2010 Feb 25;142(1):2-7. doi: 10.1016/j.jconrel.2009.09.028. Epub 2009 Oct 3.
7
Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.用于治疗细胞内细菌感染的肠胃外使用的可生物降解庆大霉素给药系统。
Expert Opin Drug Deliv. 2007 Nov;4(6):677-88. doi: 10.1517/17425247.4.6.677.
8
Development of Drug Targeting and Delivery in Cervical Cancer.宫颈癌的药物靶向与递送的发展。
Curr Cancer Drug Targets. 2018;18(8):792-806. doi: 10.2174/1568009617666171009165105.
9
In situ forming parenteral drug delivery systems: an overview.原位形成注射用药物递送系统:综述
Eur J Pharm Biopharm. 2004 Sep;58(2):445-55. doi: 10.1016/j.ejpb.2004.03.003.
10
Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.纳米化用于口服和肠外药物递送:使用湿磨介质技术对水溶性差的化合物进行制剂的观点。
Adv Drug Deliv Rev. 2011 May 30;63(6):427-40. doi: 10.1016/j.addr.2010.12.007. Epub 2011 Jan 9.

引用本文的文献

1
Acute toxicity effects of ethylene glycol on lethal dose 50 (LD), urine production, and histopathology change renal tubule cell in mice.乙二醇对小鼠半数致死量(LD)、尿量生成及肾小管细胞组织病理学变化的急性毒性作用。
Open Vet J. 2024 Dec;14(12):3539-3551. doi: 10.5455/OVJ.2024.v14.i12.36. Epub 2024 Dec 31.
2
Determination of osimertinib concentration in rat plasma and lung/brain tissues.大鼠血浆及肺/脑组织中奥希替尼浓度的测定。
Am J Transl Res. 2024 Dec 15;16(12):8008-8022. doi: 10.62347/SYZD2489. eCollection 2024.
3
Insights into interspecies protein binding variability using clindamycin as an example.以克林霉素为例深入了解种间蛋白质结合变异性
J Antimicrob Chemother. 2025 Feb 3;80(2):363-371. doi: 10.1093/jac/dkae412.
4
Interspecies variability in protein binding of antibiotics basis for translational PK/PD studies-a case study using cefazolin.抗生素蛋白结合的种间变异性——以头孢唑林为例的转化 PK/PD 研究
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0164723. doi: 10.1128/aac.01647-23. Epub 2024 Feb 20.
5
The impact of phosphodiesterase inhibition on neurobehavioral outcomes in preclinical models of traumatic and non-traumatic spinal cord injury: a systematic review.磷酸二酯酶抑制对创伤性和非创伤性脊髓损伤临床前模型神经行为结果的影响:一项系统综述
Front Med (Lausanne). 2023 Aug 22;10:1237219. doi: 10.3389/fmed.2023.1237219. eCollection 2023.
6
Imaging of large volume subcutaneous deposition using MRI: exploratory clinical study results.使用 MRI 对大面积皮下沉积进行成像:探索性临床研究结果。
Drug Deliv Transl Res. 2023 Sep;13(9):2353-2366. doi: 10.1007/s13346-023-01318-7. Epub 2023 Mar 13.
7
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials.儿童脑肿瘤:将中枢神经系统药物递送转化为临床试验的策略综述
Cancers (Basel). 2023 Jan 30;15(3):857. doi: 10.3390/cancers15030857.
8
Interspecies and in vitro-in vivo scaling for quantitative modeling of whole-body drug pharmacokinetics in patients: Application to the anticancer drug oxaliplatin.物种间和体外-体内外推法用于定量建模患者全身药物药代动力学:以抗癌药物奥沙利铂为例。
CPT Pharmacometrics Syst Pharmacol. 2023 Feb;12(2):221-235. doi: 10.1002/psp4.12895. Epub 2022 Dec 19.
9
Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.翻译抗菌药物研发中的蛋白质结合——关注种间差异
Antibiotics (Basel). 2022 Jul 8;11(7):923. doi: 10.3390/antibiotics11070923.
10
Specificity of plasma oxytocin immunoassays: A comparison of commercial assays and sample preparation techniques using oxytocin knockout and wildtype mice.血浆催产素免疫分析的特异性:使用催产素敲除和野生型小鼠比较商业分析试剂盒和样品制备技术。
Psychoneuroendocrinology. 2021 Oct;132:105368. doi: 10.1016/j.psyneuen.2021.105368. Epub 2021 Jul 26.

本文引用的文献

1
Immunogenicity of therapeutic proteins: the use of animal models.治疗性蛋白的免疫原性:动物模型的应用。
Pharm Res. 2011 Oct;28(10):2379-85. doi: 10.1007/s11095-011-0523-5. Epub 2011 Jul 9.
2
Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting.临床前预测人体脑靶部位浓度:向临床环境外推时的考虑因素。
J Pharm Sci. 2011 Sep;100(9):3577-93. doi: 10.1002/jps.22604. Epub 2011 May 4.
3
Species independence in brain tissue binding using brain homogenates.利用脑组织匀浆进行脑组织结合的物种独立性。
Drug Metab Dispos. 2011 Jul;39(7):1270-7. doi: 10.1124/dmd.111.038778. Epub 2011 Apr 7.
4
Hyaluronan-CD44 interactions as potential targets for cancer therapy.透明质酸-CD44 相互作用作为癌症治疗的潜在靶点。
FEBS J. 2011 May;278(9):1429-43. doi: 10.1111/j.1742-4658.2011.08071.x. Epub 2011 Mar 25.
5
Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [(3)H]GBR12935 binding and [(3)H]dopamine uptake.犬和啮齿动物大脑中多巴胺转运复合体的比较特性:纹状体[³H]GBR12935结合与[³H]多巴胺摄取
Neurochem Int. 1989;15(3):325-32. doi: 10.1016/0197-0186(89)90140-x.
6
Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management.透明质酸酶:已批准制剂、适应证及慢性疼痛管理中超适应证使用的综述。
Expert Opin Biol Ther. 2010 Jan;10(1):127-31. doi: 10.1517/14712590903490382.
7
Role of in vitro release models in formulation development and quality control of parenteral depots.在注射用储库制剂的开发和质量控制中,体外释放模型的作用。
Expert Opin Drug Deliv. 2009 Dec;6(12):1283-95. doi: 10.1517/17425240903307431.
8
Intranasal delivery to the central nervous system: mechanisms and experimental considerations.经鼻腔向中枢神经系统递药:机制与实验考量。
J Pharm Sci. 2010 Apr;99(4):1654-73. doi: 10.1002/jps.21924.
9
Radiopharmaceutical pharmacokinetics in animals: critical considerations.动物体内放射性药物的药代动力学:关键考量因素
Q J Nucl Med Mol Imaging. 2009 Aug;53(4):359-64.
10
Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.利用透明质酸衍生物实现蛋白质、肽和核苷酸治疗药物的靶向特异性和长效递送。
J Control Release. 2010 Jan 4;141(1):2-12. doi: 10.1016/j.jconrel.2009.09.010. Epub 2009 Sep 13.

影响在开发注射型药物传递系统中动物模型的使用和解释的因素。

Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems.

机构信息

US FDA/Center for Veterinary Medicine, Rockville, Maryland 20855, USA.

出版信息

AAPS J. 2011 Dec;13(4):632-49. doi: 10.1208/s12248-011-9303-8. Epub 2011 Oct 5.

DOI:10.1208/s12248-011-9303-8
PMID:21971647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3231859/
Abstract

Depending upon the drug and drug delivery platform, species-specific physiological differences can lead to errors in the interspecies extrapolation of drug performance. This manuscript provides an overview of the species-specific physiological variables that can influence the performance of parenteral dosage forms such as in situ forming delivery systems, nanoparticles, microspheres, liposomes, targeted delivery systems, lipophilic solutions, and aqueous suspensions. Also discussed are those factors that can influence the partitioning of therapeutic compounds into tumors, the central nervous system and the lymphatics. Understanding interspecies differences in the movement and absorption of molecules is important to the interpretation of data generated through the use of animal models when studying parenteral drug delivery.

摘要

根据药物和药物传递平台的不同,种属特异性的生理差异可能导致药物性能的种间外推出现错误。本文概述了影响各种剂型(如原位形成给药系统、纳米粒、微球、脂质体、靶向给药系统、亲脂性溶液和水混悬剂)性能的种属特异性生理变量。本文还讨论了那些可能影响治疗化合物在肿瘤、中枢神经系统和淋巴系统中分配的因素。理解分子在种属间的移动和吸收差异,对于解释通过动物模型研究给药时产生的数据非常重要。